Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 3/2020

31.01.2020 | Original Article

BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus

verfasst von: Kakara Divya, Ramesh Malothu, E. Laxmi Narayana

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Aim

The relational analysis of adenosine deaminase (ADA), nitric oxide (NO), BDNF (brain-derived neurotrophic factor), and TP (total protein) is accomplished by comparing these parameters with glucose levels of healthy and type II diabetes mellitus people. Type 2 diabetes (T2DM) is associated with impairment in many domains of cognitive function which may result from reduced BDNF. ADA is an important enzyme that plays a relevant role in purine and DNA metabolism, immune responses, and peptidase activity and for modulating the bioactivity of insulin. Nitric oxide is associated with loss of normal cellular function and increases the generation of nitric oxide synthetase products like nitroxyl (NO-), peroxynitrite (OONO-), and S-nitrosothiol (RSNO).

Method

In our study, a group of one hundred adult patients of either sex who had a history of not less than 6 years of diabetes mellitus and an equal number of healthy non-diabetics was selected as controls, respectively.

Results

The results of the parameters were analyzed using the SISA software and the correlation between the parameters was retrieved and represented graphically. A significant increase in adenosine deaminase activity and nitric oxide levels was observed in diabetic subjects when compared with that in controls. A significant decrease in total protein concentration and BDNF was observed in diabetic subjects when compared with that in controls. The results suggest that the increase in the glucose level has contributed to an increase in the inflammation factor ADA and oxidative stress factor NO and decrease in the total proteins especially BDNF, a neuron sentinel.
Literatur
2.
Zurück zum Zitat Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for prevalence of diabetes mellitus for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for prevalence of diabetes mellitus for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
3.
Zurück zum Zitat Prakash MS, Chennaiah S, Murthy YS, Anjaiah E, Rao SA, Suresh C. Altered adenosine deaminase activity in type 2 diabetes mellitus. Age. 2006;43(6.2):44–6. Prakash MS, Chennaiah S, Murthy YS, Anjaiah E, Rao SA, Suresh C. Altered adenosine deaminase activity in type 2 diabetes mellitus. Age. 2006;43(6.2):44–6.
4.
Zurück zum Zitat Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45. Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45.
5.
Zurück zum Zitat Tyler WJ, Alonso M, Bramham CR, Pozzo Miller LD. From acquisition to consolidation: on the role of brain derived neurotrophic factor (BDNF) signaling in hippo-campal dependent learning. Learning Memory. 2002;9(5):224–37.PubMedCrossRef Tyler WJ, Alonso M, Bramham CR, Pozzo Miller LD. From acquisition to consolidation: on the role of brain derived neurotrophic factor (BDNF) signaling in hippo-campal dependent learning. Learning Memory. 2002;9(5):224–37.PubMedCrossRef
6.
Zurück zum Zitat Graves DB, Bauer G. Key roles of reactive oxygen (ROS) and nitrogen species (RNS). In: Comprehensive Clinical Plasma Medicine. Cham: Springer; 2018. p. 71–82.CrossRef Graves DB, Bauer G. Key roles of reactive oxygen (ROS) and nitrogen species (RNS). In: Comprehensive Clinical Plasma Medicine. Cham: Springer; 2018. p. 71–82.CrossRef
7.
Zurück zum Zitat Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. Brain-derived neurotrophic factor (BDNF) and type II diabetes. Diabetologia. 2007;50(2):431–8. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. Brain-derived neurotrophic factor (BDNF) and type II diabetes. Diabetologia. 2007;50(2):431–8.
8.
Zurück zum Zitat Cotman CW. The role of neuro-trophins in brain aging: a perspective in honor of Regino Perez polo. Neurochem Res. 2005;30(6–7):877–81.PubMedCrossRef Cotman CW. The role of neuro-trophins in brain aging: a perspective in honor of Regino Perez polo. Neurochem Res. 2005;30(6–7):877–81.PubMedCrossRef
9.
Zurück zum Zitat Allen KV, Frier BM, Strachan MW. The relationship between type II diabetes mellitus and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004;490(1–3):169–75.PubMedCrossRef Allen KV, Frier BM, Strachan MW. The relationship between type II diabetes mellitus and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004;490(1–3):169–75.PubMedCrossRef
10.
Zurück zum Zitat Donath MY, Shoelson SE. Type II diabetes mellitus as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98.PubMedCrossRef Donath MY, Shoelson SE. Type II diabetes mellitus as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98.PubMedCrossRef
11.
Zurück zum Zitat Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994;25(2):97–102. Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994;25(2):97–102.
12.
Zurück zum Zitat Stentz FB, Kitabchi AE. Activated T lymphocytes in type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4(6):493–503.PubMedCrossRef Stentz FB, Kitabchi AE. Activated T lymphocytes in type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4(6):493–503.PubMedCrossRef
13.
Zurück zum Zitat Aruna S, Suchitra MM, Suresh V. Adenosine deaminase (ADA) activity in type II diabetes mellitus. J Clin Sci Res. 2017;6(4):254.CrossRef Aruna S, Suchitra MM, Suresh V. Adenosine deaminase (ADA) activity in type II diabetes mellitus. J Clin Sci Res. 2017;6(4):254.CrossRef
14.
Zurück zum Zitat Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica-Hradec Kralove. 2004;47(1):33–6.PubMedCrossRef Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica-Hradec Kralove. 2004;47(1):33–6.PubMedCrossRef
15.
Zurück zum Zitat Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes care. 2011;34(Supplement 2):S285–90.PubMedPubMedCentralCrossRef Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes care. 2011;34(Supplement 2):S285–90.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Ceriello PA. Oxidative stress and diabetes associated complications. Endocrine Pract. 2006;12(Supplement 1):60–2.CrossRef Ceriello PA. Oxidative stress and diabetes associated complications. Endocrine Pract. 2006;12(Supplement 1):60–2.CrossRef
17.
Zurück zum Zitat Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423–36.PubMedCrossRef Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423–36.PubMedCrossRef
18.
Zurück zum Zitat Stadler K. Peroxy-nitrite driven mechanisms in diabetes mellitus and insulin resistance -the latest advances. Curr Med Chem. 2011;18(2):280–90.PubMedPubMedCentralCrossRef Stadler K. Peroxy-nitrite driven mechanisms in diabetes mellitus and insulin resistance -the latest advances. Curr Med Chem. 2011;18(2):280–90.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin- phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin- phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed
20.
Zurück zum Zitat Ibrahim MY, Abdalla MA. Effects of Alloxan induced diabetes on blood metabolites and serum minerals and hormones in rabbit (Lepus cuniculus) in relation to starch supplementation and season. Adv Biol Res. 2011;5(1):45–58. Ibrahim MY, Abdalla MA. Effects of Alloxan induced diabetes on blood metabolites and serum minerals and hormones in rabbit (Lepus cuniculus) in relation to starch supplementation and season. Adv Biol Res. 2011;5(1):45–58.
21.
Zurück zum Zitat Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long term memory storage. Proc Natl Acad Sci. 2008;105(7):2711–6. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long term memory storage. Proc Natl Acad Sci. 2008;105(7):2711–6.
22.
Zurück zum Zitat Tapia Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of (BDNF) brain derived neurotrophic factor: focus on hypothalamic function. Front Neuroendocrinol. 2004;25(2):77–107.PubMedCrossRef Tapia Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of (BDNF) brain derived neurotrophic factor: focus on hypothalamic function. Front Neuroendocrinol. 2004;25(2):77–107.PubMedCrossRef
23.
Zurück zum Zitat Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor (BDNF) and the metabolic syndrome: more than just a hypothesis. Medical hypothesis. 2006;1(67):195–6.CrossRef Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor (BDNF) and the metabolic syndrome: more than just a hypothesis. Medical hypothesis. 2006;1(67):195–6.CrossRef
24.
Zurück zum Zitat Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor and food intake regulation: a mini review. Auton Neurosci. 2006;126:30–8.PubMedCrossRef Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor and food intake regulation: a mini review. Auton Neurosci. 2006;126:30–8.PubMedCrossRef
25.
Zurück zum Zitat Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, et al. Protective effect of brain-derived neurotrophic factor (BDNF) on pancreatic- islets in obese diabetic mice. Metabolism. 2006;55(10):1286–92. Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, et al. Protective effect of brain-derived neurotrophic factor (BDNF) on pancreatic- islets in obese diabetic mice. Metabolism. 2006;55(10):1286–92.
26.
Zurück zum Zitat Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventro-medial and dorso-medial hypothalamus of adult mice, results in hyper-phagic behavior and obesity. J Neurosci. 2007;27(52):14265–74.PubMedPubMedCentralCrossRef Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventro-medial and dorso-medial hypothalamus of adult mice, results in hyper-phagic behavior and obesity. J Neurosci. 2007;27(52):14265–74.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Layman DK, Clifton P, Gannon MC, Krauss RM, Nuttall FQ. Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr. 2008;87(5):1571S–5S.PubMedCrossRef Layman DK, Clifton P, Gannon MC, Krauss RM, Nuttall FQ. Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr. 2008;87(5):1571S–5S.PubMedCrossRef
28.
Zurück zum Zitat Powers MA. Hand-book of diabetes medical nutrition theraphy: Jones & Bartlett Learning; 1996. Powers MA. Hand-book of diabetes medical nutrition theraphy: Jones & Bartlett Learning; 1996.
29.
Zurück zum Zitat Franz MJ. Protein controversies in diabetes mellitus. Diabetes Spectrum. 2000;13(3):132. Franz MJ. Protein controversies in diabetes mellitus. Diabetes Spectrum. 2000;13(3):132.
30.
Zurück zum Zitat Giusti G. Adenosine Deaminase (ADA). In: Methods of enzymatic analysis (second edition), vol. 2; 1974. p. 1092–9.CrossRef Giusti G. Adenosine Deaminase (ADA). In: Methods of enzymatic analysis (second edition), vol. 2; 1974. p. 1092–9.CrossRef
31.
Zurück zum Zitat Sun J, Zhang X, Broderick M, Fein H. Measurement of nitric oxide (NO) production in biological systems by using Griess- reaction assay. Sensors. 2003;3(8):276–84.CrossRef Sun J, Zhang X, Broderick M, Fein H. Measurement of nitric oxide (NO) production in biological systems by using Griess- reaction assay. Sensors. 2003;3(8):276–84.CrossRef
32.
Zurück zum Zitat Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies (Mab) raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol. 1986;137(7):2299–306.PubMed Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies (Mab) raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol. 1986;137(7):2299–306.PubMed
33.
Zurück zum Zitat Loghmani ES. Nutrition therapy for overweight children and adolescents with type 2 diabetes. Current diabetes reports. 2005;5(5):385–90.PubMedCrossRef Loghmani ES. Nutrition therapy for overweight children and adolescents with type 2 diabetes. Current diabetes reports. 2005;5(5):385–90.PubMedCrossRef
34.
Zurück zum Zitat Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role? BMC Endocr Disord. 2018;18(1):58.PubMedPubMedCentralCrossRef Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role? BMC Endocr Disord. 2018;18(1):58.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Ghosh A, Sherpa ML, Yazum Bhutia RP, Dahal S. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. International Journal of Applied and Basic Medical Research. 2011;1(1):31–5.PubMedPubMedCentralCrossRef Ghosh A, Sherpa ML, Yazum Bhutia RP, Dahal S. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. International Journal of Applied and Basic Medical Research. 2011;1(1):31–5.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Scallan JP, Hill MA, Davis MJ. Lymphatic vascular integrity is disrupted in type 2 diabetes mellitus due to impaired nitric oxide signaling. Cardiovasc Res. 2015;107(1):89–97.PubMedPubMedCentralCrossRef Scallan JP, Hill MA, Davis MJ. Lymphatic vascular integrity is disrupted in type 2 diabetes mellitus due to impaired nitric oxide signaling. Cardiovasc Res. 2015;107(1):89–97.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771-776. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771-776.
38.
Zurück zum Zitat Abu-Lebdeh HS, Nair KS. Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab. 1996;10(4):589–601.PubMedCrossRef Abu-Lebdeh HS, Nair KS. Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab. 1996;10(4):589–601.PubMedCrossRef
41.
Zurück zum Zitat Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Taiji M. Brain-derived Neurotrophic- factor (BDNF) prevents the development of diabetes mellitus in pre-diabetic mice. Biomed Res. 2008;29(3):147–53.PubMedCrossRef Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Taiji M. Brain-derived Neurotrophic- factor (BDNF) prevents the development of diabetes mellitus in pre-diabetic mice. Biomed Res. 2008;29(3):147–53.PubMedCrossRef
42.
Zurück zum Zitat Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C, et al. Brain-derived neurotrophic- factor reduces the blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun. 1997;238(2):633–7. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C, et al. Brain-derived neurotrophic- factor reduces the blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun. 1997;238(2):633–7.
43.
Zurück zum Zitat Awad N, Gagnon M, Messier C. The relation-ship between impaired glucose tolerance, type II diabetes mellitus and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044–80.PubMedCrossRef Awad N, Gagnon M, Messier C. The relation-ship between impaired glucose tolerance, type II diabetes mellitus and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044–80.PubMedCrossRef
Metadaten
Titel
BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus
verfasst von
Kakara Divya
Ramesh Malothu
E. Laxmi Narayana
Publikationsdatum
31.01.2020
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 3/2020
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-019-00793-4

Weitere Artikel der Ausgabe 3/2020

International Journal of Diabetes in Developing Countries 3/2020 Zur Ausgabe